News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Major European indexes closed mostly lower, led by Amsterdam AEX down 1.15%, London -0.54%, DAX -0.14% and Paris -0.19%.
  • MACOM agreed long-term epitaxial supply deals and will invest £45 million in IQE to strengthen its chip supply chain.
  • NATO is considering ending annual leaders' summits amid concerns about contentious U.S. leadership and short-term summit outcomes.
  • A coordinated jihadi and Tuareg offensive in Mali killed the defense minister and intensified fragmentation risks across the Sahel.
  • American Airlines will raise $1.14 billion through aircraft-backed debt to fund deliveries and refinance existing aircraft loans.
  • EU regulators advised Google on opening Android AI capabilities to rivals under the Digital Markets Act, seeking feedback ahead of a July decision.

Latest Articles

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck & Co., Inc. announced an agreement to acquire Terns Pharmaceuticals, a clinical-stage oncology company, for approximately $6.7 billion. The acquisition focuses on Terns' lead investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor, TERN-701, which is in Phase 1/2 trials for chronic myeloid leukemia (CML). The deal reflects Merck's…

UBS Lowers Stance on Eurozone Stocks as Energy Disruptions Threaten Recovery

UBS Lowers Stance on Eurozone Stocks as Energy Disruptions Threaten Recovery

UBS’s Chief Investment Office moved Eurozone equities to a neutral stance and cut its 2026 earnings growth outlook to 5% from 7%, citing the risk that ongoing interruptions to energy supplies could derail a hoped-for manufacturing rebound. At the same time, the bank upgraded Swiss equities and European health care to Attractive and reiterated secto…

Arm Shares Surge After Analysts Applaud New AGI Processor

Arm Shares Surge After Analysts Applaud New AGI Processor

Arm Holdings shares jumped 13% in premarket trading after bullish analyst notes that praised the company’s first internally developed processor, co-created with Meta. Raymond James and Wolfe Research upgraded their outlooks, citing a new fabless semiconductor angle, projected earnings upgrades for FY28 and FY31, and a strong customer pipeline for a…

BYDFi Boosts European Presence as Sponsor of Next Block Expo 2026 in Warsaw

BYDFi Boosts European Presence as Sponsor of Next Block Expo 2026 in Warsaw

Global crypto trading platform BYDFi served as a sponsor at Next Block Expo 2026 in Warsaw on March 24-25, showcasing its trading infrastructure, meeting industry participants, and launching an on-site mystery blind-box giveaway featuring limited-edition merchandise tied to its Newcastle United partnership. The appearance precedes a month-long cele…

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

Kanzhun Limited, operating as BOSS Zhipin, announced the continuation and expansion of its share repurchase program, having spent nearly RMB450 million in 2026 to buy back shares. The board increased repurchase authorization to US$400 million through August 2027 and committed to allocating at least 50% of adjusted net income annually for dividends …

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics, a U.S.-based biopharmaceutical company specializing in plasma-derived biologics for immune deficiencies, has publicly addressed a negative short-seller report issued by Culper Research. The company refutes the report's assertions as speculative and false, emphasizing its compliance with regulatory standards and ongoing review of the…

Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026

Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026

Comstock Inc. announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit scheduled for April 1, 2026. The company continues to focus on innovative technologies that extract and recycle critical metals from end-of-life photovoltaics, supporting clean energy systems.

Aeluma: Buy the Manufacturing Transition - Play for Photonic Scale-Up

Aeluma: Buy the Manufacturing Transition - Play for Photonic Scale-Up

Aeluma is shifting from lab-scale IP to wafer-scale photonic manufacturing. Recent capital raises, equipment purchases, and government contract wins materially de-risk the path to commercialization. The risk-reward is asymmetric for disciplined traders: expensive on sales today but potentially re-rated if production-ready demos and incremental reve…